RVMD

161.7151.43%
JA

Jack Anders

Chief Financial Officer

Mr. Jack Anders serves as Chief Financial Officer at Revolution Medicines, Inc. since September 2022. He served as Senior Vice President of Finance at Revolution Medicines, Inc. since 2021 until September 2022. He served as Vice President of Finance at Revolution Medicines Inc. since August 2018 until 2021 and served as its Principal Accounting Officer until September 2022. Prior to joining Revolution Medicines, Mr. Anders served in various roles at Depomed, Inc. from 2006 to July 2018, including most recently as Vice President, Finance from 2013 to 2018. Mr. Anders held various managerial roles in finance and accounting at Elan Pharmaceuticals, Yahoo! and Novellus Systems. Mr. Anders began his career in the life sciences practice at PricewaterhouseCoopers LLP. Mr. Anders received a B.A. in Economics with an emphasis in Accounting from the University of California, Los Angeles and is a former certified public accountant.

Positions